Advised and represented the IDMA (Indian Drug Manufacturers’ Association) and FOPE (Foundation of Pharma Entrepreneurs) before High Court and Supreme Court in a matter pertaining to “Product Approval” for Food Business Operators (FBOs). The resultant order passed by the Hon’ble Supreme Court in this matter has led to the Product Approval Advisories being set to naught. Therefore, as such, the Product Approval advisories do not have the force of law and the entire process of obtaining a prior product approval has been struck down and there is no need for a FBO to get a prior Product Approval before launching a product in the market.
Represented IDMA (Indian Drug Manufacturers’ Association) and FOPE (Foundation of Pharma Entrepreneurs) and entire industry in successfully initiating and defending a writ petition filed against the order of Central Government by which it has banned 344 fixed dose combinations drugs expressing that these combinations lacked therapeutic rationality or justification.
Advised and represented a domestic pharmaceutical company and one of its shareholders in shareholder disputes and other disputes arising from such shareholder disputes, including but not limited to disputes with lenders, before the Delhi High Court, Company Law Board, Debt Recovery Tribunal and constituted Arbitral Tribunal.